FDC has informed that its manufacturing unit located at Roha, Dist.- Raigad, Maharashtra that manufactures Active Pharmaceutical Ingredient (APIs) products has been inspected by US FDA from 20th March 2023 to 24th March 2023. The said audit has been successfully completed by the US FDA with 'No observations' (Zero 483's). The Active Pharmaceutical Ingredients (API's) product manufactured at the above facility continues to be marketed in USA.
The above information is a part of company’s filings submitted to BSE
